Isoflurane hepatitis

Infections in Medicine

Volumn 13, Issue 4, 1996, Pages 322-324

  Thill, Rodney H ^a,b   Millikan, Keith W ^a,b   Doolas, Alexander ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of General Surgery ^*  (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

anesthesia; complications, anesthesia; hepatitis; isoflurane; liver; systemic inflammatory response syndrome (SIRS)

Indexed keywords

ISOFLURANE;

ADULT; ARTICLE; CASE REPORT; COLON RESECTION; FEVER; HEPATITIS; HUMAN; LIVER FAILURE; LIVER TOXICITY; MALE; RASH;

EID: 0029933701     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barash PG, Cullen BF, Stoelting RK: Clinical Anesthesia, ed 2. Philadelphia, JB Lippincott Co., 1992, pp 473-474.
2. Brunt EM, White H, Marsh JW, et al: Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: A case report. Hepatology 13:1017-1021, 1991.
3. Carrigan TW, Straughen WJ: A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology 67:581-583, 1987.
4. Gregoire S, Smiley RK: Acute hepatitis in a patient with mild factor IX deficiency after anesthesia with isoflurane. CMAJ 135:645-646, 1986.
5. Stoelting RK, Blitt CD, Cohen PJ, et al: Hepatic dysfunction after isoflurane anesthesia. Anesth Analg 66:147-153, 1987.
6. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846, 1954.
7. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455, 1992.
8. Summary of the national Halothane Study: Possible association between halothane anesthesia and postoperative hepatic necrosis. JAMA 197:775-778, 1966.
9. Schiff L, Schiff ER (eds): Diseases of the liver, ed 7, Philadelphia, JB Lippincott Co., 1993, pp 742-744.
10. McLain GE, Sipes IG, Brown BR: An animal model of halothane hepatotoxicity: Roles of enzyme induction and hypoxia. Anesthesiology 51:321-326, 1979.
11. Vergani D, Mieli-Vergani G, Alberti A, et al: Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303:66-71, 1980.
12. Eger EI: Isoflurane: A review. Anesthesiology 55:559-576, 1981.
13. Render K, Forbes J, Alter H, et al: Halothane biotransformation in man: A quantitative study. Anesthesiology 28:711-715, 1967.
14. Holaday D, Fiserova-Bergerova V, Latto I, et al: Resistance of isoflurane to biotransformation in man. Anesthesiology 43:325-332, 1975.
15. Goldfarb G, Rogier E, Gebauer C, et al: Comparative effects of halothane and isoflurane anesthesia on the ultrastructure of human hepatic cells. Anesth Analg 69:491-495, 1989.
16. VanDyke RA: Hepatic centrilobular necrosis in rats after exposure to halothane, enflurane, or isoflurane. Anesth Analg 61:812-819, 1982.
17. Harper MH, Collins P, Johnson B, et al: Hepatic injury following halothane, enflurane, and isoflurane anesthesia in rats. Anesthesiology 56:14-17, 1982.